Close Menu

NEW YORK (GenomeWeb News) – Becton Dickinson said on Thursday it has entered into a five-year agreement for the creation of an unsecured revolving credit facility for up to $1.5 billion.

The facility, which expires in May 2017, provides BD with $1 billion of financing, as well as access to an additional $500 million of financing, subject to additional commitments by the lenders.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.